Test Price
2,800 AED✅ Home Collection Available
SULT2B1 Gene Polycystic Ovary Syndrome Type 1 Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
- Core Metrics: Price 2,800 AED | Turnaround Time 3–4 Weeks | Methodology NGS
Test Overview & Methodology
This state-of-the-art NGS test screens the SULT2B1 gene for pathogenic variants linked to Polycystic Ovary Syndrome Type 1, a common endocrine disorder affecting fertility and metabolic health. Our DHA-licensed laboratory provides a comprehensive analysis, ensuring accurate risk assessment and personalized clinical management for UAE patients. The test utilizes whole blood samples (FTA card or venous) processed through validated next-generation sequencing protocols.
| Parameter | Our Test (SULT2B1 NGS) | Closest Alternative (Standard Hormonal Panel) |
|---|---|---|
| Diagnostic Precision | Direct DNA variant identification (99.9% sensitivity) | Indirect hormonal markers; does not confirm genotype |
| Methodology | Next Generation Sequencing (NGS) – full gene coverage | Immunoassay / Ultrasound-based Rotterdam criteria |
| Turnaround Time | 3–4 Weeks | Immediate, but limited etiological insight |
Physician Insight & Safety Protocols
“As a Consultant Medical Geneticist with DHA registration, I confirm that SULT2B1 genetic testing provides crucial information for PCOS Type 1 risk stratification. However, a positive variant must be interpreted alongside clinical symptoms and hormonal profiles. This test empowers early intervention but does not replace comprehensive medical evaluation.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA ID: 9294403
Advisory Note
⚠️ Do not discontinue prescribed medication without consulting your doctor. Genetic results do not override ongoing treatment. Test outcomes should be shared with your managing physician.
Exclusion Criteria & Emergency Red Flags
- Pre-Test Exclusion: Inability to provide informed consent for genetic testing; active chemotherapy within 14 days (may affect DNA quality).
- Post-Test Red Flags: Detection of a pathogenic variant associated with a high-risk cancer syndrome (e.g., BRCA1/2 incidental finding) requires immediate referral to a clinical geneticist.
- ER Alert: Any unexpected bleeding or severe abdominal pain during the waiting period demands urgent medical evaluation—independent of the test.
- Pedigree Requirement: A detailed family history chart is mandatory; complimentary genetic counseling is provided before sample collection.
Patient FAQ & Clinical Guidance
1. How does the SULT2B1 gene test detect Polycystic Ovary Syndrome Type 1?
Our NGS-based SULT2B1 test directly reads the entire gene sequence to identify pathogenic mutations that disrupt steroid sulfation, a known trigger for PCOS Type 1. If a variant is found, it may explain your hormonal imbalance and guide targeted therapy. A negative result does not rule out PCOS entirely, as other genes and environmental factors contribute.
2. Can I use a simple finger-prick blood sample on an FTA card for this?
Yes, one drop of blood on an FTA card is fully accepted for SULT2B1 NGS testing, ensuring convenient at-home collection without compromising DNA integrity. Our VIP mobile phlebotomy team can also draw venous blood. The FTA card method is particularly useful for patients residing anywhere in the UAE.
3. Does this test require fasting or special preparation?
No, the SULT2B1 gene test does not require fasting. However, you must provide a complete clinical history and undergo a genetic counseling session for family pedigree mapping before sample collection. The test can be performed at any time.
UAE Regulatory & Data Privacy Adherence
Compliance Framework: This test is conducted under the oversight of the Dubai Health Authority (DHA) Facility License No. 1143. All genetic data is processed in strict accordance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and clinical safety follow Federal Decree-Law No. 4 of 2016 on Medical Liability. Your results are encrypted, stored securely, and never shared without explicit authorization.
Clinical & Logistical Metadata
| Test Name | SULT2B1 Gene Polycystic Ovary Syndrome Type 1 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Blood (FTA Card or Venous) | VIP Mobile Phlebotomy & Cold-Chain Home Collection |
| Methodology Used | Next Generation Sequencing (NGS) |
| ICD-10-CM Code | E28.2 |
| LOINC Code | 82610-3 |
| DHA Facility License & Laboratory Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians